NIH-funded research NIH-funded research

A new bandage to prevent infections in burn wounds

Official title: A Compliant Superhydrophobic Antimicrobial Photodynamic Therapy Bandage for the Prevention of Multidrug Resistant Wound Infections

Funded at Singleto2 Therapeutics, LLC · NIH-10920772 · Data updated 2026-11-12

This study is testing a new type of bandage that helps prevent infections in burn wounds by using light to kill harmful bacteria, making it safer and more effective for healing without relying on traditional antibiotics.

More Wound research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSingleto2 Therapeutics, LLC
NIH-funded
Lab location1 site (Summit, UNITED STATES)
Project startApril 12, 2024
Project endMarch 31, 2026
Funding year2024
Award (this year)$300,000
NIH project number1R41AI183969-01
Project IDNIH-10920772 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with burn wounds who are at risk of developing multidrug-resistant infections.

Less likely to help

Patients with non-burn related wounds or those not at risk for multidrug-resistant infections may not benefit from this research.

What this research studies

This research focuses on developing an innovative bandage designed to prevent infections caused by multidrug-resistant bacteria in burn wounds. The bandage utilizes antimicrobial photodynamic therapy (aPDT) by delivering airborne singlet oxygen, which effectively kills bacteria without introducing drugs into the wound. This approach minimizes the risk of bacterial resistance and enhances the healing process. The bandage's unique superhydrophobic design allows for controlled delivery of treatment while reducing direct contact with the wound.

Why it matters

Potential benefit: If successful, this research could significantly reduce the incidence of infections in burn patients, leading to better recovery outcomes.

How similar studies have gone: Previous research has shown promise with antimicrobial photodynamic therapy, but this specific approach using a superhydrophobic bandage is novel.

Where this research is happening

  • Singleto2 Therapeutics, LLC
    Summit, United States
    Active

Researchers

  • Principal investigator: Xu, Qianfeng — Singleto2 Therapeutics, LLC
  • Study coordinator: Xu, Qianfeng

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.